시장보고서

상품코드

1552779

감각이상 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Paresthesia Treatment Market (Type: Acute Paresthesia and Chronic Paresthesia; and Indication: Radiculopathy and Neuropathy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

발행일: 2024년 07월 | 리서치사:

Transparency Market Research | 페이지 정보: 영문 154 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

감각이상 치료 시장 - 조사 범위

TMR의 조사 보고서 "세계 감각이상 치료 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측연도로 하여 2018년부터 2034년까지의 세계 감각이상 치료 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 감각이상 치료 시장의 복합 연간 성장률(CAGR %)도 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 감각이상 치료 시장을 이해하고자 했습니다.

시장 스냅샷
2023년 시장 규모	54억 달러
2034년 시장 규모	80억 달러
CAGR	3.7%

이 보고서는 세계 감각이상 치료 시장의 경쟁 환경을 조사하고 있습니다. 세계 감각이상 치료 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 소개하는 세계 감각이상 치료 시장 기업의 속성입니다.

시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석 : 기업별(2023)
기업 개요
- Pfizer Inc.
- Novartis AG
- GSK PLC
- Merck & Co., Inc.
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- Eli Lilly & Co.
- Sanofi S.A.

ksm 24.10.04

Paresthesia Treatment Market - Scope of Report

TMR's report on the global paresthesia treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global paresthesia treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global paresthesia treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the paresthesia treatment market.

Market Snapshot
Market Value in 2023	US$ 5.4 Bn
Market Value in 2034	US$ 8 Bn
CAGR	3.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global paresthesia treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global paresthesia treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global paresthesia treatment market.

The report delves into the competitive landscape of the global paresthesia treatment market. Key players operating in the global paresthesia treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global paresthesia treatment market profiled in this report.

Key Questions Answered in Global paresthesia treatment Market Report:

What is the sales/revenue generated by paresthesia treatment across all regions during the forecast period?
What are the opportunities in the global paresthesia treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Paresthesia Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global paresthesia treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global paresthesia treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global paresthesia treatment market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Paresthesia Treatment Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Paresthesia Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Paresthesia Treatment Market Analysis and Forecast, by Type

6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
- 6.3.1. Acute Paresthesia
- 6.3.2. Chronic Paresthesia
6.4. Market Attractiveness, by Type

7. Global Paresthesia Treatment Market Analysis and Forecast, by Treatment

7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Treatment, 2020-2034
- 7.3.1. Immunosuppressants
- 7.3.2. Anticonvulsants
- 7.3.3. Topical Creams
- 7.3.4. Antivirals
7.4. Market Attractiveness, by Treatment

8. Global Paresthesia Treatment Market Analysis and Forecast, by Indication

8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2020-2034
- 8.3.1. Radiculopathy
- 8.3.2. Neuropathy
8.4. Market Attractiveness, by Indication

9. Global Paresthesia Treatment Market Analysis and Forecast, by End-user

9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Online Pharmacies
9.4. Market Attractiveness, by End-user

10. Global Paresthesia Treatment Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region

11. North America Paresthesia Treatment Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2020-2034
- 11.2.1. Acute Paresthesia
- 11.2.2. Chronic Paresthesia
11.3. Market Attractiveness, by Type
11.4. Market Value Forecast, by Treatment, 2020-2034
- 11.4.1. Immunosuppressants
- 11.4.2. Anticonvulsants
- 11.4.3. Topical Creams
- 11.4.4. Antivirals
11.5. Market Attractiveness, by Treatment
11.6. Market Value Forecast, by Indication, 2020-2034
- 11.6.1. Radiculopathy
- 11.6.2. Neuropathy
11.7. Market Attractiveness, by Indication
11.8. Market Value Forecast, by End-user, 2020-2034
- 11.8.1. Hospital Pharmacies
- 11.8.2. Retail Pharmacies
- 11.8.3. Online Pharmacies
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.10.1. U.S.
- 11.10.2. Canada
11.11. Market Attractiveness Analysis
- 11.11.1. By Type
- 11.11.2. By Treatment
- 11.11.3. By Indication
- 11.11.4. By End-user
- 11.11.5. By Country

12. Europe Paresthesia Treatment Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2034
- 12.2.1. Acute Paresthesia
- 12.2.2. Chronic Paresthesia
12.3. Market Attractiveness, by Type
12.4. Market Value Forecast, by Treatment, 2020-2034
- 12.4.1. Immunosuppressants
- 12.4.2. Anticonvulsants
- 12.4.3. Topical Creams
- 12.4.4. Antivirals
12.5. Market Attractiveness, by Treatment
12.6. Market Value Forecast, by Indication, 2020-2034
- 12.6.1. Radiculopathy
- 12.6.2. Neuropathy
12.7. Market Attractiveness, by Indication
12.8. Market Value Forecast, by End-user, 2020-2034
- 12.8.1. Hospital Pharmacies
- 12.8.2. Retail Pharmacies
- 12.8.3. Online Pharmacies
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.10.1. Germany
- 12.10.2. U.K.
- 12.10.3. France
- 12.10.4. Italy
- 12.10.5. Spain
- 12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
- 12.11.1. By Type
- 12.11.2. By Treatment
- 12.11.3. By Indication
- 12.11.4. By End-user
- 12.11.5. By Country/Sub-region

13. Asia Pacific Paresthesia Treatment Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2034
- 13.2.1. Acute Paresthesia
- 13.2.2. Chronic Paresthesia
13.3. Market Attractiveness, by Type
13.4. Market Value Forecast, by Treatment, 2020-2034
- 13.4.1. Immunosuppressants
- 13.4.2. Anticonvulsants
- 13.4.3. Topical Creams
- 13.4.4. Antivirals
13.5. Market Attractiveness, by Treatment
13.6. Market Value Forecast, by Indication, 2020-2034
- 13.6.1. Radiculopathy
- 13.6.2. Neuropathy
13.7. Market Attractiveness, by Indication
13.8. Market Value Forecast, by End-user, 2020-2034
- 13.8.1. Hospital Pharmacies
- 13.8.2. Retail Pharmacies
- 13.8.3. Online Pharmacies
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.10.1. China
- 13.10.2. Japan
- 13.10.3. India
- 13.10.4. Australia & New Zealand
- 13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
- 13.11.1. By Type
- 13.11.2. By Treatment
- 13.11.3. By Indication
- 13.11.4. By End-user
- 13.11.5. By Country/Sub-region

14. Latin America Paresthesia Treatment Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2034
- 14.2.1. Acute Paresthesia
- 14.2.2. Chronic Paresthesia
14.3. Market Attractiveness, by Type
14.4. Market Value Forecast, by Treatment, 2020-2034
- 14.4.1. Immunosuppressants
- 14.4.2. Anticonvulsants
- 14.4.3. Topical Creams
- 14.4.4. Antivirals
14.5. Market Attractiveness, by Treatment
14.6. Market Value Forecast, by Indication, 2020-2034
- 14.6.1. Radiculopathy
- 14.6.2. Neuropathy
14.7. Market Attractiveness, by Indication
14.8. Market Value Forecast, by End-user, 2020-2034
- 14.8.1. Hospital Pharmacies
- 14.8.2. Retail Pharmacies
- 14.8.3. Online Pharmacies
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.10.1. Brazil
- 14.10.2. Mexico
- 14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
- 14.11.1. By Type
- 14.11.2. By Treatment
- 14.11.3. By Indication
- 14.11.4. By End-user
- 14.11.5. By Country/Sub-region

15. Middle East & Africa Paresthesia Treatment Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2020-2034
- 15.2.1. Acute Paresthesia
- 15.2.2. Chronic Paresthesia
15.3. Market Attractiveness, by Type
15.4. Market Value Forecast, by Treatment, 2020-2034
- 15.4.1. Immunosuppressants
- 15.4.2. Anticonvulsants
- 15.4.3. Topical Creams
- 15.4.4. Antivirals
15.5. Market Attractiveness, by Treatment
15.6. Market Value Forecast, by Indication, 2020-2034
- 15.6.1. Radiculopathy
- 15.6.2. Neuropathy
15.7. Market Attractiveness, by Indication
15.8. Market Value Forecast, by End-user, 2020-2034
- 15.8.1. Hospital Pharmacies
- 15.8.2. Retail Pharmacies
- 15.8.3. Online Pharmacies
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 15.10.1. GCC Countries
- 15.10.2. South Africa
- 15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
- 15.11.1. By Type
- 15.11.2. By Treatment
- 15.11.3. By Indication
- 15.11.4. By End-user
- 15.11.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
- 16.3.1. Pfizer Inc.
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Product Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. Novartis AG
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Product Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. GSK PLC
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Product Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Merck & Co., Inc.
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Product Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. Johnson & Johnson
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Product Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Teva Pharmaceutical Industries Ltd.
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Product Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. AbbVie Inc.
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Product Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. Amgen Inc.
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Product Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. AstraZeneca plc
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Product Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview
- 16.3.10. Bayer AG
  - 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.10.2. Product Portfolio
  - 16.3.10.3. Financial Overview
  - 16.3.10.4. SWOT Analysis
  - 16.3.10.5. Strategic Overview
- 16.3.11. Eli Lilly & Co.
  - 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.11.2. Product Portfolio
  - 16.3.11.3. Financial Overview
  - 16.3.11.4. SWOT Analysis
  - 16.3.11.5. Strategic Overview
- 16.3.12. Sanofi S.A.
  - 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.12.2. Product Portfolio
  - 16.3.12.3. Financial Overview
  - 16.3.12.4. SWOT Analysis
  - 16.3.12.5. Strategic Overview

감각이상 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Paresthesia Treatment Market (Type: Acute Paresthesia and Chronic Paresthesia; and Indication: Radiculopathy and Neuropathy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

감각이상 치료 시장 - 조사 범위

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계의 시장 분석과 예측 : 유형별

제7장 세계의 시장 분석과 예측 : 치료별

제8장 세계의 시장 분석과 예측 : 적응증별

제9장 세계의 시장 분석과 예측 : 최종사용자별

제10장 세계의 시장 분석과 예측 : 지역별

제11장 북미의 시장 분석과 예측

제12장 유럽의 시장 분석과 예측

제13장 아시아태평양의 시장 분석과 예측

제14장 라틴아메리카의 시장 분석과 예측

제15장 중동 및 아프리카의 시장 분석과 예측

제16장 경쟁 상황